Description
John Wiley Biomarkers In Brain Disease by Lovestone
Advances in biomarker development are revolutionizing the way westudy, diagnose and treat disease. However, progress in thedevelopment and use of biomarkers for diseases of the centralnervous system has been limited by a number of difficulties ––including the inherent barriers associated with studying the brain.Development of reliable biomarkers for brain disorders woulddramatically accelerate research on the etiology, pathophysiology,disease progression, and therapeutic development of many veryprevalent and devastating diseases including Alzheimer's disease,Parkinson's disease, multiple sclerosis, and others. Internationalexperts in the field have contributed chapters to this volume thatdiscuss the latest advances in biomarker technologies and biomarkerdevelopment for brain disorders, as well as the logistical,regulatory and funding challenges experienced by scientists workingon clinical trials for biomarkers.